To assess the clinical relevance of SEMA3C in ER+ breast cancer, we analyzed publicly available clinical datasets to investigate the association between SEMA3C expression and patient characteristics, as well as the correlation of SEMA3C with known breast-cancer-associated genes. Here, SEMA3C is linked to breast cancer.